TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis by Ritam Joarder, Dhwani Patel, Atul Tiwari, Jatin Choudhary, Pranaya Vana, Vallish Shenoy, Neha Mer, Anant Ramaswamy, Prabhat Bhargava, Vikas Ostwal

Get full text